Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)
$26.03-0.08%Close
SELLBEAR · day 32
Key stats
- Market cap
- $1.3B
- Beta
- 0.14
- P/E (TTM)
- -26.29
- 1W
- +0.12%
- 1M
- -0.04%
- vs SPY 1W
- -1.04%
- vs SPY 1M
- -3.03%
Industry peers
FMP comparable companies · ranked by market cap
- BKDSELLBrookdale Senior Living Inc.$2.6BCRISISQ 5$10.77-7.07%
- AGTIAgiliti, Inc.$1.4B$10.05
- PNTPOINT Biopharma Global Inc.$1.3B$12.50
- HSKAHeska Corporation$1.3B$119.99
- CINCCinCor Pharma, Inc.$1.3B$29.06
- CTICCTI BioPharma Corp.$1.2B$9.10
- EQRXEQRx, Inc.$1.1B$2.34
- SILKSilk Road Medical, Inc$1.1B$27.49
- FNAParagon 28, Inc.$1.1B$13.09
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on HROWM?
- LOPJLB’s latest quantitative signal on Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is HROWM in?
- Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) do?
- Harrow Health, Inc. focuses on the creation, production, and marketing of cutting-edge pharmaceutical solutions. Its business activities are primarily organized into two distinct divisions: Pharmaceutical Compounding and Pharmaceutical Drug Development. Specifically, the Pharmaceutical Compounding segment oversees the operations of the ImprimisRx enterprise. The company was established in Janua…